Skip to Main Content
Try STAT+ TODAY
Trending:
The Obesity Revolution
Biotech
Health
First Opinion
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
Pharma
STAT+

Week of March 13: What to watch for in biopharma

By Dylan Scott March 13, 2017

Reprints
The Week Ahead
Alex Hogan/STAT

Happy Monday, everybody. It’s a big week in Washington. So here are the happenings in the nation’s capital and everything else to watch for this week in biopharmaceuticals.

Trumpcare, all the time

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Author Reprints

Dylan Scott

Washington Correspondent

Tags

The case of RaDonda Vaught highlights a double standard…
The case of RaDonda Vaught highlights a double standard for nurses and physicians
23andMe had devastating news about my health. I wish…
23andMe had devastating news about my health. I wish a person had delivered it
‘Three Identical Strangers’: It’s not too late to address…
‘Three Identical Strangers’: It’s not too late to address the ethical violations
California judge deals GSK a setback as first Zantac…
California judge deals GSK a setback as first Zantac lawsuit will now go to trial
Up and down the ladder: The latest comings and…
Up and down the ladder: The latest comings and goings
Pharmalittle: EU delays pharma legislation again; India cancels license…
Pharmalittle: EU delays pharma legislation again; India cancels license for maker of cough syrup linked to…

Recommended Stories